BiotechTube

Drug-Carbamazepine (Tegretol XR) + Carbamazepine (Tegretol XR) Placebo

Phase 2Terminated
0 views this week 0 watching💤 Quiet
Interest: 27/100
27
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Alpha-1-antitrypsin Deficiency

Conditions

Alpha-1-antitrypsin Deficiency, Liver Cirrhosis

Trial Timeline

Jan 1, 2012 → Feb 1, 2017

NCT ID
NCT01379469

About Drug-Carbamazepine (Tegretol XR) + Carbamazepine (Tegretol XR) Placebo

Drug-Carbamazepine (Tegretol XR) + Carbamazepine (Tegretol XR) Placebo is a phase 2 stage product being developed by Novartis for Alpha-1-antitrypsin Deficiency. The current trial status is terminated. This product is registered under clinical trial identifier NCT01379469. Target conditions include Alpha-1-antitrypsin Deficiency, Liver Cirrhosis.

Hype Score Breakdown

Clinical
12
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01379469Phase 2Terminated